rutherford health plc Company Information
Company Number
09420705
Website
www.proton-int.comRegistered Address
10 fleet place, london, EC4M 7QS
Industry
Activities of head offices
Telephone
01633810661
Next Accounts Due
611 days late
Group Structure
View All
Shareholders
nortrust nominees limited 81.7%
cruisen ltd 10.9%
View Allrutherford health plc Estimated Valuation
Pomanda estimates the enterprise value of RUTHERFORD HEALTH PLC at £2.5m based on a Turnover of £7.3m and 0.34x industry multiple (adjusted for size and gross margin).
rutherford health plc Estimated Valuation
Pomanda estimates the enterprise value of RUTHERFORD HEALTH PLC at £0 based on an EBITDA of £-23.6m and a 2.31x industry multiple (adjusted for size and gross margin).
rutherford health plc Estimated Valuation
Pomanda estimates the enterprise value of RUTHERFORD HEALTH PLC at £388.2m based on Net Assets of £144.7m and 2.68x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Rutherford Health Plc Overview
Rutherford Health Plc is a live company located in london, EC4M 7QS with a Companies House number of 09420705. It operates in the activities of head offices sector, SIC Code 70100. Founded in February 2015, it's largest shareholder is nortrust nominees limited with a 81.7% stake. Rutherford Health Plc is a young, mid sized company, Pomanda has estimated its turnover at £7.3m with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
Rutherford Health Plc Health Check
Pomanda's financial health check has awarded Rutherford Health Plc a 2.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 7 areas for improvement. Company Health Check FAQs
4 Strong
0 Regular
7 Weak
Size
annual sales of £7.3m, make it smaller than the average company (£17.4m)
£7.3m - Rutherford Health Plc
£17.4m - Industry AVG
Growth
3 year (CAGR) sales growth of 639%, show it is growing at a faster rate (0.3%)
639% - Rutherford Health Plc
0.3% - Industry AVG
Production
with a gross margin of -4.7%, this company has a higher cost of product (31.6%)
-4.7% - Rutherford Health Plc
31.6% - Industry AVG
Profitability
an operating margin of -428.4% make it less profitable than the average company (3.9%)
-428.4% - Rutherford Health Plc
3.9% - Industry AVG
Employees
with 223 employees, this is above the industry average (122)
223 - Rutherford Health Plc
122 - Industry AVG
Pay Structure
on an average salary of £49.3k, the company has a higher pay structure (£40.3k)
£49.3k - Rutherford Health Plc
£40.3k - Industry AVG
Efficiency
resulting in sales per employee of £32.6k, this is less efficient (£152.6k)
£32.6k - Rutherford Health Plc
£152.6k - Industry AVG
Debtor Days
it gets paid by customers after 191 days, this is later than average (45 days)
191 days - Rutherford Health Plc
45 days - Industry AVG
Creditor Days
its suppliers are paid after 138 days, this is slower than average (45 days)
138 days - Rutherford Health Plc
45 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Rutherford Health Plc
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 2 weeks, this is less cash available to meet short term requirements (18 weeks)
2 weeks - Rutherford Health Plc
18 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 16.3%, this is a lower level of debt than the average (59.6%)
16.3% - Rutherford Health Plc
59.6% - Industry AVG
RUTHERFORD HEALTH PLC financials
Rutherford Health Plc's latest turnover from February 2021 is £7.3 million and the company has net assets of £144.7 million. According to their latest financial statements, Rutherford Health Plc has 223 employees and maintains cash reserves of £1.5 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Feb 2021 | Feb 2020 | Feb 2019 | Feb 2018 | Feb 2017 | Feb 2016 | |
---|---|---|---|---|---|---|
Turnover | 7,269,000 | 5,606,000 | 1,465,000 | 18,000 | 0 | 0 |
Other Income Or Grants | 0 | 0 | 0 | 0 | ||
Cost Of Sales | 7,611,000 | 5,190,000 | 2,872,000 | 0 | ||
Gross Profit | -342,000 | 416,000 | -1,407,000 | 18,000 | ||
Admin Expenses | 30,799,000 | 26,077,000 | 17,718,000 | 10,572,000 | ||
Operating Profit | -31,141,000 | -25,661,000 | -19,125,000 | -10,554,000 | -5,879,000 | -3,048,000 |
Interest Payable | 1,300,000 | 3,615,000 | 2,393,000 | 1,034,000 | 6,000 | 0 |
Interest Receivable | 0 | 0 | 0 | 77,000 | 82,000 | 88,000 |
Pre-Tax Profit | -32,441,000 | -29,276,000 | -21,518,000 | -11,511,000 | -5,817,000 | -2,960,000 |
Tax | 213,000 | 4,842,000 | 3,253,000 | 2,832,000 | -11,000 | 0 |
Profit After Tax | -32,228,000 | -24,434,000 | -18,265,000 | -8,679,000 | -5,828,000 | -2,960,000 |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
Retained Profit | -32,228,000 | -24,434,000 | -18,265,000 | -8,679,000 | -5,828,000 | -2,960,000 |
Employee Costs | 10,997,000 | 10,115,000 | 7,798,000 | 4,600,000 | 2,124,000 | 661,000 |
Number Of Employees | 223 | 170 | 124 | 68 | 37 | 10 |
EBITDA* | -23,642,000 | -19,641,000 | -15,641,000 | -9,551,000 | -5,574,000 | -2,967,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Feb 2021 | Feb 2020 | Feb 2019 | Feb 2018 | Feb 2017 | Feb 2016 | |
---|---|---|---|---|---|---|
Tangible Assets | 171,844,000 | 174,705,000 | 143,055,000 | 105,045,000 | 62,564,000 | 25,236,000 |
Intangible Assets | 60,000 | 300,000 | 541,000 | 0 | 0 | 0 |
Investments & Other | 0 | 3,704,000 | 0 | 4,163,000 | 4,163,000 | 0 |
Debtors (Due After 1 year) | 10,342,000 | 10,342,000 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 161,562,000 | 164,663,000 | 143,596,000 | 105,045,000 | 62,564,000 | 25,236,000 |
Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Debtors | 3,823,000 | 591,000 | 175,000 | 0 | 97,000 | 0 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 5,642,000 | 9,122,000 | 6,740,000 | 7,210,000 | 2,590,000 | 2,804,000 |
Cash | 1,493,000 | 19,157,000 | 20,589,000 | 6,695,000 | 35,141,000 | 27,305,000 |
misc current assets | 0 | 0 | 0 | 31,000 | 0 | 0 |
total current assets | 11,418,000 | 29,380,000 | 27,504,000 | 13,936,000 | 37,828,000 | 30,109,000 |
total assets | 172,980,000 | 194,043,000 | 171,100,000 | 118,981,000 | 100,392,000 | 55,345,000 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 2,886,000 | 13,123,000 | 25,992,000 | 11,007,000 | 2,402,000 | 292,000 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 17,582,000 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 59,000 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 7,087,000 | 2,821,000 | 2,183,000 | 811,000 | 351,000 | 433,000 |
total current liabilities | 27,614,000 | 15,944,000 | 28,175,000 | 11,818,000 | 2,753,000 | 725,000 |
loans | 1,264,000 | 21,172,000 | 49,030,000 | 26,298,000 | 17,546,000 | 0 |
hp & lease commitments | 632,000 | 706,000 | 778,000 | 415,000 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 632,000 | 10,586,000 | 24,515,000 | 13,149,000 | 8,773,000 | 0 |
total liabilities | 28,246,000 | 26,530,000 | 52,690,000 | 24,967,000 | 11,526,000 | 725,000 |
net assets | 144,734,000 | 167,513,000 | 118,410,000 | 94,014,000 | 88,866,000 | 54,620,000 |
total shareholders funds | 144,734,000 | 167,513,000 | 118,410,000 | 94,014,000 | 88,866,000 | 54,620,000 |
Feb 2021 | Feb 2020 | Feb 2019 | Feb 2018 | Feb 2017 | Feb 2016 | |
---|---|---|---|---|---|---|
Operating Activities | ||||||
Operating Profit | -31,141,000 | -25,661,000 | -19,125,000 | -10,554,000 | -5,879,000 | -3,048,000 |
Depreciation | 7,259,000 | 5,779,000 | 3,484,000 | 1,003,000 | 305,000 | 81,000 |
Amortisation | 240,000 | 241,000 | 0 | 0 | 0 | 0 |
Tax | 213,000 | 4,842,000 | 3,253,000 | 2,832,000 | -11,000 | 0 |
Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors | -248,000 | 13,140,000 | -295,000 | 4,523,000 | -117,000 | 2,804,000 |
Creditors | -10,237,000 | -12,869,000 | 14,985,000 | 8,605,000 | 2,110,000 | 292,000 |
Accruals and Deferred Income | 4,266,000 | 638,000 | 1,372,000 | 460,000 | -82,000 | 433,000 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | -29,152,000 | -40,170,000 | 4,264,000 | -2,177,000 | -3,440,000 | -5,046,000 |
Investing Activities | ||||||
capital expenditure | ||||||
Change in Investments | -3,704,000 | 3,704,000 | -4,163,000 | 0 | 4,163,000 | 0 |
cash flow from investments | ||||||
Financing Activities | ||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 17,582,000 | 0 | 0 | 0 | 0 | 0 |
Long term loans | -19,908,000 | -27,858,000 | 22,732,000 | 8,752,000 | 17,546,000 | 0 |
Hire Purchase and Lease Commitments | -15,000 | -72,000 | 363,000 | 415,000 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | ||||||
interest | -1,300,000 | -3,615,000 | -2,393,000 | -957,000 | 76,000 | 88,000 |
cash flow from financing | 5,808,000 | 41,992,000 | 63,363,000 | 22,037,000 | 57,696,000 | 57,668,000 |
cash and cash equivalents | ||||||
cash | -17,664,000 | -1,432,000 | 13,894,000 | -28,446,000 | 7,836,000 | 27,305,000 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | -17,664,000 | -1,432,000 | 13,894,000 | -28,446,000 | 7,836,000 | 27,305,000 |
rutherford health plc Credit Report and Business Information
Rutherford Health Plc Competitor Analysis
Perform a competitor analysis for rutherford health plc by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other mid companies, companies in EC4M area or any other competitors across 12 key performance metrics.
rutherford health plc Ownership
RUTHERFORD HEALTH PLC group structure
Rutherford Health Plc has 7 subsidiary companies.
Ultimate parent company
RUTHERFORD HEALTH PLC
09420705
7 subsidiaries
rutherford health plc directors
Rutherford Health Plc currently has 5 directors. The longest serving directors include Prof Karol Sikora (Jul 2015) and Mr Andrew Bennett (Nov 2019).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Prof Karol Sikora | 76 years | Jul 2015 | - | Director | |
Mr Andrew Bennett | United Kingdom | 55 years | Nov 2019 | - | Director |
Mr Marcus King | England | 42 years | Feb 2021 | - | Director |
Mr Mark Jackson | Wales | 68 years | Dec 2021 | - | Director |
Dr Mahdi Alfardan | 55 years | Feb 2022 | - | Director |
P&L
February 2021turnover
7.3m
+30%
operating profit
-31.1m
+21%
gross margin
-4.7%
-163.4%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
February 2021net assets
144.7m
-0.14%
total assets
173m
-0.11%
cash
1.5m
-0.92%
net assets
Total assets minus all liabilities
rutherford health plc company details
company number
09420705
Type
Public limited with Share Capital
industry
70100 - Activities of head offices
incorporation date
February 2015
age
9
incorporated
UK
ultimate parent company
accounts
Group
last accounts submitted
February 2021
previous names
proton partners international limited (August 2019)
accountant
-
auditor
PRICEWATERHOUSECOOPERS LLP
address
10 fleet place, london, EC4M 7QS
Bank
BARCLAYS CORPORATE BANK PLC
Legal Advisor
-
rutherford health plc Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 6 charges/mortgages relating to rutherford health plc. Currently there are 3 open charges and 3 have been satisfied in the past.
rutherford health plc Companies House Filings - See Documents
date | description | view/download |
---|